{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:10:08Z","timestamp":1755792608053,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,21]]},"DOI":"10.7759\/cureus.90674","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:31:48Z","timestamp":1755790308000},"source":"Crossref","is-referenced-by-count":0,"title":["Past Marks: A Case Report of Basal Cell Carcinoma Induced by Arsenic Exposure"],"prefix":"10.7759","author":[{"given":"Patr\u00edcia","family":"Carreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Constantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Basal cell carcinoma. Epidemiology, pathogenesis, clinical features, and diagnosis - UpToDate. (2024). Accessed: October 14, 2024: https:\/\/www.uptodate.com\/contents\/basal-cell-carcinoma-epidemiology-pathogenesis-clinical-features-and-diagnosis."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225598","article-title":"Interaction of arsenic exposure and transcriptomic profile in basal cell carcinoma","volume":"14","author":"Kibriya MG","year":"2022","unstructured":"Kibriya MG, Jasmine F, Munoz A, et al.. Interaction of arsenic exposure and transcriptomic profile in basal cell carcinoma. Cancers (Basel). 2022, 14:5598. 10.3390\/cancers14225598","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3495","article-title":"Update in the management of basal cell carcinoma","volume":"100","author":"Basset-Seguin N","year":"2020","unstructured":"Basset-Seguin N, Herms F. Update in the management of basal cell carcinoma. Acta Derm Venereol. 2020, 100:adv00140. 10.2340\/00015555-3495","journal-title":"Acta Derm Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22699","article-title":"Multiple cutaneous carcinoma arising from arsenic-containing traditional Chinese medicine in a patient with psoriasis: a case report","volume":"9","author":"Li W","year":"2023","unstructured":"Li W, Li X, Xu C, Sun S, Yao C. Multiple cutaneous carcinoma arising from arsenic-containing traditional Chinese medicine in a patient with psoriasis: a case report. Heliyon. 2023, 9:e22699. 10.1016\/j.heliyon.2023.e22699","journal-title":"Heliyon"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfr184","article-title":"Arsenic exposure and toxicology: a historical perspective","volume":"123","author":"Hughes MF","year":"2011","unstructured":"Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011, 123:305-32. 10.1093\/toxsci\/kfr184","journal-title":"Toxicol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad113.298","article-title":"H16 arsenic to biologics: psoriasis treatment through the ages","volume":"188","author":"Sarfraz R","year":"2023","unstructured":"Sarfraz R. H16 arsenic to biologics: psoriasis treatment through the ages. Br J Dermatol. 2023, 188:10.1093\/bjd\/ljad113.298","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16152746","article-title":"Arsenic-induced carcinogenesis and immune dysregulation","volume":"16","author":"Huang HW","year":"2019","unstructured":"Huang HW, Lee CH, Yu HS. Arsenic-induced carcinogenesis and immune dysregulation. Int J Environ Res Public Health. 2019, 16:2746. 10.3390\/ijerph16152746","journal-title":"Int J Environ Res Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0960327107084539","article-title":"Arsenic neurotoxicity--a review","volume":"26","author":"Vahidnia A","year":"2007","unstructured":"Vahidnia A, van der Voet GB, de Wolff FA. Arsenic neurotoxicity--a review. Hum Exp Toxicol. 2007, 26:823-32. 10.1177\/0960327107084539","journal-title":"Hum Exp Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.79.933.391","article-title":"Acute and chronic arsenic toxicity","volume":"79","author":"Ratnaike RN","year":"2003","unstructured":"Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J. 2003, 79:391-6. 10.1136\/pmj.79.933.391","journal-title":"Postgrad Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11373-006-9092-8","article-title":"Arsenic carcinogenesis in the skin","volume":"13","author":"Yu HS","year":"2006","unstructured":"Yu HS, Liao WT, Chai CY. Arsenic carcinogenesis in the skin. J Biomed Sci. 2006, 13:657-66. 10.1007\/s11373-006-9092-8","journal-title":"J Biomed Sci"},{"key":"ref11","unstructured":"Arsenic - World Health Organization. (2022). Accessed. October 14, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/arsenic ."},{"key":"ref12","unstructured":"Minimal risk levels (MRLs) - Agency for Toxic Substances and Disease Registry. (2024). Accessed. June 2025: https:\/\/www.atsdr.cdc.gov\/mrls\/pdfs\/ATSDR-MRLs-December-2024-H.pdf."},{"key":"ref13","article-title":"Toxicological Profile for Arsenic","author":"Agency for Toxic Substances and Disease Registry","year":"2007","unstructured":"Agency for Toxic Substances and Disease Registry. Toxicological Profile for Arsenic. U.S. Department of Health and Human Services, 2007."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13058","article-title":"Relationship between arsenic-containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan","volume":"43","author":"Cheng PS","year":"2016","unstructured":"Cheng PS, Weng SF, Chiang CH, Lai FJ. Relationship between arsenic-containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan. J Dermatol. 2016, 43:181-6. 10.1111\/1346-8138.13058","journal-title":"J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-12-73","article-title":"Arsenic immunotoxicity: a review","volume":"12","author":"Dangleben NL","year":"2013","unstructured":"Dangleben NL, Skibola CF, Smith MT. Arsenic immunotoxicity: a review. Environ Health. 2013, 12:73. 10.1186\/1476-069X-12-73","journal-title":"Environ Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1289\/EHP8152","article-title":"Rare, protein-altering variants in AS3MT and arsenic metabolism efficiency: a multi-population association study","volume":"129","author":"Delgado DA","year":"2021","unstructured":"Delgado DA, Chernoff M, Huang L, et al.. Rare, protein-altering variants in AS3MT and arsenic metabolism efficiency: a multi-population association study. Environ Health Perspect. 2021, 129:47007. 10.1289\/EHP8152","journal-title":"Environ Health Perspect"},{"key":"ref17","article-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Vismodegib. National Institutes of Health, Bethesda, MD; 2012."},{"key":"ref18","article-title":"Erivedge (Vismodegib) Capsules: Prescribing information","author":"U.S. Food and Drug Administration","year":"2016","unstructured":"U.S. Food and Drug Administration . Erivedge (Vismodegib) Capsules: Prescribing information. U.S. Food and Drug Administration, Silver Spring, MD; 2016."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222969","article-title":"Hepatotoxicity associated with vismodegib","volume":"2018","author":"Bedi PS","year":"2018","unstructured":"Bedi PS, Rai MP, Tageja N, Laird-Fick H. Hepatotoxicity associated with vismodegib. BMJ Case Rep. 2018, 2018:bcr2017222969. 10.1136\/bcr-2017-222969","journal-title":"BMJ Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.09.021","article-title":"A case of hepatotoxicity associated with vismodegib","volume":"5","author":"Ly P","year":"2019","unstructured":"Ly P, Wolf K, Wilson J. A case of hepatotoxicity associated with vismodegib. JAAD Case Rep. 2019, 5:57-9. 10.1016\/j.jdcr.2018.09.021","journal-title":"JAAD Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323537-past-marks-a-case-report-of-basal-cell-carcinoma-induced-by-arsenic-exposure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:31:49Z","timestamp":1755790309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323537-past-marks-a-case-report-of-basal-cell-carcinoma-induced-by-arsenic-exposure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.90674","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}